Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Grant of ESOP'.
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals has informed stock exchanges that its Nomination and Remuneration Committee, at a meeting held on July 24, 2025, approved the grant of 2,72,500 employee stock options (ESOPs) under the company's Employees Stock Option Plan, 2022. Each option is exercisable at Rs. 216 per option and is convertible into one equity share of Rs. 2 face value. The options will vest in 4 equal annual tranches, starting from the first anniversary of the grant date. The intimation has been filed with both BSE (Scrip Code: 507789) and NSE (Symbol: JAGSNPHARM).
This is a routine ESOP allotment and is likely to cause minor dilution for existing shareholders once options are exercised, but no immediate impact on share price is expected. Employees receiving the options at Rs. 216 may benefit if the stock trades above this level when options are exercised.